A quantitative index measured on 99mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease
详细信息 查看全文
- 作者：Morikatsu Yoshida (1) (5)
Shinya Shiraishi (1)
Fumi Sakaguchi (1)
Daisuke Utsunomiya (1)
Kuniyuki Tashiro (2)
Seiji Tomiguchi (3)
Hirohisa Okabe (4)
Toru Beppu (4)
Hideo Baba (4)
Yasuyuki Yamashita (1) - 关键词：99mTc ; GSA SPECT/CT 3D fused image ; Liver uptake ratio ; Functional liver index ; Chronic liver disease ; Liver cirrhosis
- 刊名：Japanese Journal of Radiology
- 出版年：2012
- 出版时间：June 2012
- 年：2012
- 卷：30
- 期：5
- 页码：435-441
- 全文大小：351KB
- 参考文献：1. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229:210-. CrossRef
2. Eckelman WC, Reba RC, Gibson RE, Rzeszotarski WJ, Vieras F, Mazaitis JK, et al. Receptor-binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med. 1979;20:350-.
3. Ha-Kawa SK, Kojima M, Suga Y, Kurokawa H, Itagaki Y, Tanaka Y. Dose estimation of Tc-99m-DTPA-galactosyl-human serum albumin (Tc-99m-GSA) in the blood with nonlinear regression method. Kaku Igaku. 1991;28:425-.
4. Shuke N, Okizaki A, Kino S, Sato J, Ishikawa Y, Zhao C, et al. Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT. J Nucl Med. 2003;44:475-2.
5. Kaibori M, Ha-Kawa SK, Ishizaki M, Matsui K, Saito T, Kwon AH, et al. HA/GSA-Rmax ratio as a predictor of postoperative liver failure. World J Surg. 2008;32:2410-. CrossRef
6. Miki K, Kubota K, Kokudo N, Inoue Y, Bandai Y, Makuuchi M. Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin. J Nucl Med. 1997;38:1798-07.
7. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, Sugimoto T, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673-1. CrossRef
8. Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed (99m)Tc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol. 2011;46(7):938-3. CrossRef
9. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:8. CrossRef
10. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377-2. CrossRef
11. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 1995;117:429-4. CrossRef
12. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003;30:845-. CrossRef
13. Tanaka A, Shinohara H, Hatano E, Sato S, Kanazawa A, Yamaoka Y, et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium99m galactosyl human serum albumin. Hepatogastroenterology. 1999;46:369-5.
14. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev. 1971;51:23-5 (Review).
15. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974;41:99-28.
16. Marshall JS, Green AM, Pensky J, Williams S, Zinn A, Carlson DM. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Investig. 1974;54:555-2. CrossRef
17. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology. 1981;81:527-3.
18. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426-. CrossRef
19. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med. 1999;40:1652-.
20. Kira T, Tomiguchi S, Takahashi M, Yoshimatsu S, Sagara K, Kurano R. Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med. 1999;17:125-0.
21. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med. 1991;32:2233-0.
22. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. J Nucl Med. 1991;32:1169-6.
23. Sugahara K, Togashi H, Takahashi K, Onodera Y, Sanjo M, Misawa K, et al. Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology. 2003;38:1401-.
24. Zeintl J, Vija AH, Yahil A, Hornegger J, Kuwert T. Quantitative accuracy of clinical 99mTc SPECT/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction. J Nucl Med Off Publ Soc Nucl Med. 2010;51:921-.
25. Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. J Nucl Med. 2005;46:868-7.
26. Kashiwagi T, Yutani K, Fukuchi M, Naruse H, Iwasaki T, Yokozuka K, et al. Correction of nonuniform attenuation and image fusion in SPECT imaging by means of separate X-ray CT. Ann Nucl Med. 2002;16:255-1. CrossRef
27. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 1998;5:187-2. CrossRef
28. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic-thrombocytopenia. J Clin Investig. 1966;45:645-7. CrossRef
29. Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 1985;5:638-2. CrossRef
30. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med. 1998;37:568-5. CrossRef
31. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-6. CrossRef
32. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001;96:3142-. CrossRef
33. Matsuzaki S, Onda M, Tajiri T, Kim DY. Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology. 1997;25:828-2. CrossRef - 作者单位：Morikatsu Yoshida (1) (5)
Shinya Shiraishi (1)
Fumi Sakaguchi (1)
Daisuke Utsunomiya (1)
Kuniyuki Tashiro (2)
Seiji Tomiguchi (3)
Hirohisa Okabe (4)
Toru Beppu (4)
Hideo Baba (4)
Yasuyuki Yamashita (1)
1. Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
5. Department of Radiology, Kumamoto University, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan
2. Kumamoto City Hospital, Kumamoto, Japan
3. Department of Diagnostic Medical Imaging, School of Health Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
4. Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
文摘
Purpose We compared quantitative indices estimated by use of technetium-99m galactosyl human serum albumin (99mTc-GSA) single-photon emission computed tomography (SPECT)/computed tomography (CT) fused imaging and hepatic fibrosis in patients with chronic liver disease. Materials and methods On the basis of pathological findings we divided 161 patients into non-severe and severe fibrosis groups (n?=?81 and n?=?80, respectively). We measured 2 indices by 99mTc-GSA SPECT/CT fused imaging: liver uptake value (LUV)?=?[radioactivity (whole liver)/radioactivity (injected)]?×?100/body surface area, and functional liver index (FLI)?=?[radioactivity (hepatocytes)/radioactivity (injected)]?×?100/liver volume. We compared these indices with biochemical and histopathological results. Results Univariate and multivariate analyses showed that FLI, LUV, LHL15, and prothrombin time were significant independent predictors of severe fibrosis. On the basis of receiver operating characteristics analysis, the areas under curve values of FLI, LUV, LHL15, and prothrombin time for predicting severe fibrosis were 0.83, 0.73, 0.69, and 0.68, respectively. Using an FLI value of 0.053, it was possible to predict severe fibrosis with 65?% sensitivity, 88?% specificity, and 76?% accuracy. Conclusion Assessment of functional hepatocytes by use of 99mTc-GSA SPECT/CT fused images is useful for identifying pathological liver fibrosis.